基于药房的丁丙诺啡获取途径扩大。
Pharmacy-based expansion of buprenorphine access.
机构信息
Psychiatry and Human Behavior and Medicine, Brown University, United States of America; The Miriam and Rhode Island Hospitals, United States of America.
Opioid Policy Research Collaborative, United States of America; The Heller School of Policy and Management, Brandeis University, United States of America.
出版信息
J Subst Use Addict Treat. 2024 Feb;157:209195. doi: 10.1016/j.josat.2023.209195. Epub 2023 Oct 17.
INTRODUCTION
Access to evidence-based medication treatment is a challenge for most Americans with opioid use disorder. New models of collaborative care that actively incorporate pharmacists are being trialed.
METHODS
We author a commentary based on our experiences providing clinical care as part of a randomized controlled trial of pharmacy-based addiction care.
RESULTS
This commentary describes some of the experiences of working with a Collaborative Practice Agreement between pharmacists and physicians to provide pharmacy-based, low-threshold buprenorphine access.
CONCLUSION
Given that 87 % of Americans with opioid use disorder are not getting access to buprenorphine or methadone, establishing a pharmacy-based buprenorphine treatment program is a promising strategy to address that gap and should be explored promptly.
引言
对于大多数患有阿片类药物使用障碍的美国人来说，获得基于证据的药物治疗是一个挑战。正在试验新的合作护理模式，积极纳入药剂师。
方法
我们根据在参与一项基于随机对照试验的药物成瘾护理中的临床护理经验撰写了一篇评论。
结果
该评论描述了一些与药剂师和医生之间的合作实践协议合作的经验，以提供基于药房的、低门槛的丁丙诺啡获取途径。
结论
鉴于 87%的阿片类药物使用障碍患者无法获得丁丙诺啡或美沙酮，建立基于药房的丁丙诺啡治疗方案是解决这一差距的有希望的策略，应尽快探索。
Zotero 插件